{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:36:37Z","timestamp":1761489397517},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,6,18]],"date-time":"2014-06-18T00:00:00Z","timestamp":1403049600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1038\/ejhg.2014.118","type":"journal-article","created":{"date-parts":[[2014,6,18]],"date-time":"2014-06-18T10:22:30Z","timestamp":1403086950000},"page":"409-412","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Germline PTPN11 and somatic PIK3CA variant in a boy with megalencephaly-capillary malformation syndrome (MCAP) - pure coincidence?"],"prefix":"10.1038","volume":"23","author":[{"given":"Dennis","family":"D\u00f6cker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Max","family":"Schubach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moritz","family":"Menzel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christiane","family":"Spaich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heinz-Dieter","family":"Gabriel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Zenker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah","family":"Bartholdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saskia","family":"Biskup","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,6,18]]},"reference":[{"key":"BFejhg2014118_CR1","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/(SICI)1096-8628(19970502)70:1<67::AID-AJMG13>3.0.CO;2-V","volume":"70","author":"CA Moore","year":"1997","unstructured":"Moore CA, Toriello HV, Abuelo DN et al: Macrocephaly-cutis marmorata telangiectatica congenita: a distinct disorder with developmental delay and connective tissue abnormalities. Am J Med Genet 1997; 70: 67\u201373.","journal-title":"Am J Med Genet"},{"key":"BFejhg2014118_CR2","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1097\/00019605-199710000-00001","volume":"6","author":"J Clayton-Smith","year":"1997","unstructured":"Clayton-Smith J, Kerr B, Brunner H et al: Macrocephaly with cutis marmorata, haemangioma and syndactyly\u2014a distinctive overgrowth syndrome. Clin Dysmorphol 1997; 6: 291\u2013302.","journal-title":"Clin Dysmorphol"},{"key":"BFejhg2014118_CR3","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.1002\/ajmg.a.31971","volume":"143A","author":"HV Toriello","year":"2007","unstructured":"Toriello HV, Mulliken JB : Accurately renaming macrocephaly-cutis marmorata telangiectatica congenita (M-CMTC) as macrocephaly-capillary malformation (M-CM). Am J Med Genet A 2007; 143A: 3009.","journal-title":"Am J Med Genet A"},{"key":"BFejhg2014118_CR4","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/ajmg.a.34402","volume":"158A","author":"GM Mirzaa","year":"2012","unstructured":"Mirzaa GM, Conway RL, Gripp KW et al: Megalencephaly-capillary malformation (MCAP) and megalencephaly-polydactyly-polymicrogyria-hydrocephalus (MPPH) syndromes: two closely related disorders of brain overgrowth and abnormal brain and body morphogenesis. Am J Med Genet A 2012; 158A: 269\u2013291.","journal-title":"Am J Med Genet A"},{"key":"BFejhg2014118_CR5","unstructured":"Mirzaa G, Conway R, Graham JM, Dobyns WB : PIK3CA-related segmental overgrowth 1993 http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK153722\/ Last update 2013."},{"key":"BFejhg2014118_CR6","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1002\/ajmg.c.31361","volume":"163C","author":"GM Mirzaa","year":"2013","unstructured":"Mirzaa GM, Riviere JB, Dobyns WB : Megalencephaly syndromes and activating mutations in the PI3K-AKT pathway: MPPH and MCAP. Am J Med Genet C Semin Med Genet 2013; 163C: 122\u2013130.","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"BFejhg2014118_CR7","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1038\/ng.2331","volume":"44","author":"JB Riviere","year":"2012","unstructured":"Riviere JB, Mirzaa GM, O'Roak BJ et al: De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes. Nat Genet 2012; 44: 934\u2013940.","journal-title":"Nat Genet"},{"issue":"8","key":"BFejhg2014118_CR8","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1038\/ejhg.2013.280","volume":"22","author":"Dennis D\u00f6cker","year":"2013","unstructured":"D\u00f6cker D, Schubach M, Menzel M et al: Further delineation of the SATB2 phenotype. Eur J Hum Genet 2013, e-pub ahead of print 4 December 2013; doi:10.1038\/ejhg.2013.280.","journal-title":"European Journal of Human Genetics"},{"key":"BFejhg2014118_CR9","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/ajmg.a.30813","volume":"136","author":"DR Bertola","year":"2005","unstructured":"Bertola DR, Pereira AC, Passetti F et al: Neurofibromatosis-Noonan syndrome: molecular evidence of the concurrence of both disorders in a patient. Am J Med Genet A 2005; 136: 242\u2013245.","journal-title":"Am J Med Genet A"},{"key":"BFejhg2014118_CR10","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.recesp.2012.09.017","volume":"66","author":"A Carcavilla","year":"2013","unstructured":"Carcavilla A, Santome JL, Pinto I et al: LEOPARD Syndrome: a variant of Noonan syndrome strongly associated with hypertrophic cardiomyopathy. Rev Esp Cardiol 2013; 66: 350\u2013356.","journal-title":"Rev Esp Cardiol"},{"key":"BFejhg2014118_CR11","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.beem.2010.09.002","volume":"25","author":"M Tartaglia","year":"2011","unstructured":"Tartaglia M, Gelb BD, Zenker M : Noonan syndrome and clinically related disorders. Best Pract Res Clin Endocrinol Metab 2011; 25: 161\u2013179.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"Suppl 2","key":"BFejhg2014118_CR12","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1159\/000243782","volume":"72","author":"M Zenker","year":"2009","unstructured":"Zenker M : Genetic and pathogenetic aspects of Noonan syndrome and related disorders. Horm Res 2009; 72 (Suppl 2): 57\u201363.","journal-title":"Horm Res"},{"key":"BFejhg2014118_CR13","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1016\/j.ajhg.2012.05.006","volume":"90","author":"KC Kurek","year":"2012","unstructured":"Kurek KC, Luks VL, Ayturk UM et al: Somatic mosaic activating mutations in PIK3CA cause CLOVES syndrome. Am J Hum Genet 2012; 90: 1108\u20131115.","journal-title":"Am J Hum Genet"},{"key":"BFejhg2014118_CR14","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1038\/ng.2332","volume":"44","author":"MJ Lindhurst","year":"2012","unstructured":"Lindhurst MJ, Parker VE, Payne F et al: Mosaic overgrowth with fibroadipose hyperplasia is caused by somatic activating mutations in PIK3CA. Nat Genet 2012; 44: 928\u2013933.","journal-title":"Nat Genet"},{"key":"BFejhg2014118_CR15","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/ng.2329","volume":"44","author":"JH Lee","year":"2012","unstructured":"Lee JH, Huynh M, Silhavy JL et al: De novo somatic mutations in components of the PI3K-AKT3-mTOR pathway cause hemimegalencephaly. Nat Genet 2012; 44: 941\u2013945.","journal-title":"Nat Genet"},{"key":"BFejhg2014118_CR16","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1093\/hmg\/dds440","volume":"22","author":"JJ Rios","year":"2013","unstructured":"Rios JJ, Paria N, Burns DK et al: Somatic gain-of-function mutations in PIK3CA in patients with macrodactyly. Hum Mol Genet 2013; 22: 444\u2013451.","journal-title":"Hum Mol Genet"},{"key":"BFejhg2014118_CR17","doi-asserted-by":"publisher","first-page":"192","DOI":"10.18632\/aging.100296","volume":"3","author":"LS Steelman","year":"2011","unstructured":"Steelman LS, Chappell WH, Abrams SL et al: Roles of the Raf\/MEK\/ERK and PI3K\/PTEN\/Akt\/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging. Aging (Albany NY) 2011; 3: 192\u2013222.","journal-title":"Aging (Albany NY)"},{"key":"BFejhg2014118_CR18","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1002\/ajmg.a.32040","volume":"143A","author":"RL Conway","year":"2007","unstructured":"Conway RL, Pressman BD, Dobyns WB et al: Neuroimaging findings in macrocephaly-capillary malformation: a longitudinal study of 17 patients. Am J Med Genet A 2007; 143A: 2981\u20133008.","journal-title":"Am J Med Genet A"},{"key":"BFejhg2014118_CR19","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/ajmg.a.30235","volume":"130A","author":"P Lapunzina","year":"2004","unstructured":"Lapunzina P, Gairi A, Delicado A et al: Macrocephaly-cutis marmorata telangiectatica congenita: report of six new patients and a review. Am J Med Genet A 2004; 130A: 45\u201351.","journal-title":"Am J Med Genet A"},{"key":"BFejhg2014118_CR20","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1001\/archdermatol.2008.545","volume":"145","author":"DR Wright","year":"2009","unstructured":"Wright DR, Frieden IJ, Orlow SJ et al: The misnomer \"macrocephaly-cutis marmorata telangiectatica congenita syndrome\": report of 12 new cases and support for revising the name to macrocephaly-capillary malformations. Arch Dermatol 2009; 145: 287\u2013293.","journal-title":"Arch Dermatol"},{"key":"BFejhg2014118_CR21","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.ccr.2005.01.010","volume":"7","author":"MG Mohi","year":"2005","unstructured":"Mohi MG, Williams IR, Dearolf CR et al: Prognostic, therapeutic, and mechanistic implications of a mouse model of leukemia evoked by Shp2 (PTPN11) mutations. Cancer Cell 2005; 7: 179\u2013191.","journal-title":"Cancer Cell"},{"key":"BFejhg2014118_CR22","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.3324\/haematol.2011.046896","volume":"97","author":"CB Goodwin","year":"2012","unstructured":"Goodwin CB, Yang Z, Yin F, Yu M, Chan RJ : Genetic disruption of the PI3K regulatory subunits, p85alpha, p55alpha, and p50alpha, normalizes mutant PTPN11-induced hypersensitivity to GM-CSF. Haematologica 2012; 97: 1042\u20131047.","journal-title":"Haematologica"},{"key":"BFejhg2014118_CR23","doi-asserted-by":"publisher","first-page":"2838","DOI":"10.1182\/blood-2013-10-535104","volume":"123","author":"CB Goodwin","year":"2014","unstructured":"Goodwin CB, Li XJ, Mali RS et al: PI3K p110delta uniquely promotes gain-of-function Shp2-induced GM-CSF hypersensitivity in a model of JMML. Blood 2014; 123: 2838\u20132842.","journal-title":"Blood"},{"key":"BFejhg2014118_CR24","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.pharmthera.2013.12.004","volume":"142","author":"J Polivka Jr.","year":"2013","unstructured":"Polivka J Jr., Janku F : Molecular targets for cancer therapy in the PI3K\/AKT\/mTOR pathway. Pharmacol Ther 2013; 142: 164\u2013175.","journal-title":"Pharmacol Ther"},{"key":"BFejhg2014118_CR25","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1161\/CIRCRESAHA.108.179754","volume":"103","author":"TM Marin","year":"2008","unstructured":"Marin TM, Clemente CF, Santos AM et al: Shp2 negatively regulates growth in cardiomyocytes by controlling focal adhesion kinase\/Src and mTOR pathways. Circ Res 2008; 103: 813\u2013824.","journal-title":"Circ Res"},{"key":"BFejhg2014118_CR26","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1172\/JCI44972","volume":"121","author":"TM Marin","year":"2011","unstructured":"Marin TM, Keith K, Davies B et al: Rapamycin reverses hypertrophic cardiomyopathy in a mouse model of LEOPARD syndrome-associated PTPN11 mutation. J Clin Invest 2011; 121: 1026\u20131043.","journal-title":"J Clin Invest"},{"key":"BFejhg2014118_CR27","doi-asserted-by":"publisher","first-page":"H231","DOI":"10.1152\/ajpheart.00665.2011","volume":"302","author":"C Schramm","year":"2012","unstructured":"Schramm C, Fine DM, Edwards MA, Reeb AN, Krenz M : The PTPN11 loss-of-function mutation Q510E-Shp2 causes hypertrophic cardiomyopathy by dysregulating mTOR signaling. Am J Physiol Heart Circ Physiol 2012; 302: H231\u2013H243.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"BFejhg2014118_CR28","doi-asserted-by":"publisher","first-page":"H1531","DOI":"10.1152\/ajpheart.00216.2011","volume":"301","author":"H Ishida","year":"2011","unstructured":"Ishida H, Kogaki S, Narita J et al: LEOPARD-type SHP2 mutant Gln510Glu attenuates cardiomyocyte differentiation and promotes cardiac hypertrophy via dysregulation of Akt\/GSK-3beta\/beta-catenin signaling. Am J Physiol Heart Circ Physiol 2011; 301: H1531\u2013H1539.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"BFejhg2014118_CR29","doi-asserted-by":"publisher","first-page":"e22769","DOI":"10.1371\/journal.pone.0022769","volume":"6","author":"F Janku","year":"2011","unstructured":"Janku F, Lee JJ, Tsimberidou AM et al: PIK3CA mutations frequently coexist with RAS and BRAF mutations in patients with advanced cancers. PLoS One 2011; 6: e22769.","journal-title":"PLoS One"},{"key":"BFejhg2014118_CR30","doi-asserted-by":"crossref","unstructured":"Yoda Y, Takeshima H, Niwa T et al: Integrated analysis of cancer-related pathways affected by genetic and epigenetic alterations in gastric cancer. Gastric Cancer 2014.","DOI":"10.1007\/s10120-014-0348-0"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ejhg2014118.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ejhg2014118","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ejhg2014118.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:11:13Z","timestamp":1684429873000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ejhg2014118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,18]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["BFejhg2014118"],"URL":"https:\/\/doi.org\/10.1038\/ejhg.2014.118","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,18]]},"assertion":[{"value":"22 March 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2014","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2014","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}